Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vincent Rajkumar

Showing results (41-50 of 724) with videos related to

Pageof 73
Sort By:
Mayo Clinic Proceedings|July 13, 2004
Thalidomide: tragic past and promising futureS Vincent Rajkumar
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2009
Prevention of progression in monoclonal gammopathy of undetermined significanceS Vincent Rajkumar
The Lancet. Oncology|September 23, 2014
Panobinostat for the treatment of multiple myelomaS Vincent Rajkumar
Clinical Advances in Hematology & Oncology : H&O|March 19, 2008
Controversies regarding the use of dexamethasone in patients with multiple myelomaS Vincent Rajkumar
Blood|April 11, 2015
Macro-questS Vincent Rajkumar
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 2023
Defining Myeloma and Advancing Treatment Options: A Conversation Between S. Vincent Rajkumar and Lale KostakogluS Vincent Rajkumar, Lale Kostakoglu
Blood|September 10, 2008
Many facets of bortezomib resistance/susceptibilityShaji Kumar, S Vincent Rajkumar
Clinical Lymphoma & Myeloma|October 16, 2008
Consolidation therapy with bortezomib/lenalidomide/ dexamethasone versus bortezomib/dexamethasone after a dexamethasone-based induction regimen in patients with multiple myeloma: a randomized phase III trialRafael Fonseca, S Vincent Rajkumar
Mayo Clinic Proceedings|July 6, 2020
Leaks of Clinical Trial Data and Research IntegrityS Vincent Rajkumar, Priya Sampathkumar
Blood Cancer Journal|March 29, 2023
Multiple myeloma with acute light chain cast nephropathyNelson Leung, S Vincent Rajkumar
Pageof 73

Showing results (41-50 of 724) with videos related to

Sort By:
Pageof 73
Mayo Clinic Proceedings|July 13, 2004
Thalidomide: tragic past and promising futureS Vincent Rajkumar
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2009
Prevention of progression in monoclonal gammopathy of undetermined significanceS Vincent Rajkumar
The Lancet. Oncology|September 23, 2014
Panobinostat for the treatment of multiple myelomaS Vincent Rajkumar
Clinical Advances in Hematology & Oncology : H&O|March 19, 2008
Controversies regarding the use of dexamethasone in patients with multiple myelomaS Vincent Rajkumar
Blood|April 11, 2015
Macro-questS Vincent Rajkumar
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 2023
Defining Myeloma and Advancing Treatment Options: A Conversation Between S. Vincent Rajkumar and Lale KostakogluS Vincent Rajkumar, Lale Kostakoglu
Blood|September 10, 2008
Many facets of bortezomib resistance/susceptibilityShaji Kumar, S Vincent Rajkumar
Clinical Lymphoma & Myeloma|October 16, 2008
Consolidation therapy with bortezomib/lenalidomide/ dexamethasone versus bortezomib/dexamethasone after a dexamethasone-based induction regimen in patients with multiple myeloma: a randomized phase III trialRafael Fonseca, S Vincent Rajkumar
Mayo Clinic Proceedings|July 6, 2020
Leaks of Clinical Trial Data and Research IntegrityS Vincent Rajkumar, Priya Sampathkumar
Blood Cancer Journal|March 29, 2023
Multiple myeloma with acute light chain cast nephropathyNelson Leung, S Vincent Rajkumar
Pageof 73